Illustration of a clinic building (not a photo of Greater Baltimore Medical Center, Inc.)
Illustration

Robert B. Donegan, MD

Hematology/oncology in Baltimore, MD

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • Offers telehealth
  • 35 years since graduation
  • Public record — not managed by the clinician

About Dr. Robert Donegan

Dr. Robert Donegan is a physician specializing in hematology/oncology practicing in Baltimore, MD, a graduate of University of Maryland School of Medicine (1991). Records list 2 practice addresses. Affiliated with Greater Baltimore Medical Center, Gilchrist Hospice Care, Inc. Treated 530 Medicare patients in 2024.

Provider details

SpecialtyHematology/oncologyOther hematology/oncology doctors in Baltimore
CredentialsMD
EducationUniversity of Maryland School of Medicine, 1991CMS Doctors and Clinicians
GenderMale
NPI number1689624181National Provider Identifier (CMS NPPES), issued May 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Dr. Robert Donegan's specialties and state licenses

  • Medical Oncology Primary
    License: MD D56919

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Robert Donegan practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Robert Donegan

  • Greater Baltimore Medical CenterHospital · Baltimore, MD
  • Gilchrist Hospice Care, IncHospice · Hunt Valley, MD

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Robert Donegan's Medicare patients and services (2024)

530Medicare patients
1,606services billed
75average patient age
85%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more512$130.23
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's485$16.76
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more348$184.24
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more90$224.54
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or61$32.66
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more32$81.13
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes23$176.31

Common conditions among these patients

  • High cholesterol75%
  • Cancer74%
  • High blood pressure69%
  • Arthritis48%
  • Osteoporosis27%
  • Anxiety disorders22%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Robert Donegan (2025)

$251.93 in 11 general payments reported in 2025.

TypePaymentsAmount
Food and beverage11$251.93

Paying companies: Janssen Biotech, Inc. ($72.97), Daiichi Sankyo Inc. ($29.56), Celgene Corporation ($27.28), Merck Sharp & Dohme LLC ($25.58), Regeneron Healthcare Solutions, Inc. ($24.83), NOVARTIS PHARMACEUTICALS CORPORATION ($24.81).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Also at Greater Baltimore Medical Center, Inc.

Questions about Dr. Robert Donegan

What kind of clinician is Dr. Robert Donegan?

Dr. Robert Donegan is listed as a physician specializing in hematology/oncology.

Where does Dr. Robert Donegan practice?

Greater Baltimore Medical Center, Inc. at 6715 N Charles St, Baltimore, MD 21204, and 1 other address in the records.

What is the NPI number of Dr. Robert Donegan?

The National Provider Identifier is 1689624181.

Does Dr. Robert Donegan accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Robert Donegan affiliated with?

Greater Baltimore Medical Center, Gilchrist Hospice Care, Inc.

Where did Dr. Robert Donegan go to medical school?

University of Maryland School of Medicine, graduating in 1991.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2011-10-07
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

Need an appointment?

Visit the clinic page to see how to book.

Clinic page
0 clinics selected Compare